Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis.

Infection with the agent of human granulocytic ehrlichiosis occurs in areas in which Borrelia burgdorferi and Babesia microti are endemic.1–4 The most likely vector of human granulocytic ehrlichiosis is the deer tick, Ixodes scapularis, which is also the vector of Lyme disease and babesiosis.3,4 Coinfection in humans with both the agent of human granulocytic ehrlichiosis and B. burgdorferi can be anticipated because ixodes ticks infected with the two organisms have been identified in several locales.3–5 The diagnosis of simultaneous infection with B. burgdorferi and the agent of human granulocytic ehrlichiosis is important because the natural history of . . .

[1]  D. Fish,et al.  Prevalence of the rickettsial agent of human granulocytic ehrlichiosis in ticks from a hyperendemic focus of Lyme disease. , 1997, The New England journal of medicine.

[2]  R. Nadelman,et al.  Leukopenia, thrombocytopenia, and Lyme borreliosis: is there an association? , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  J. Nowakowski,et al.  Positive Lyme disease serology in patients with clinical and laboratory evidence of human granulocytic ehrlichiosis. , 1997, American journal of clinical pathology.

[4]  J. Nowakowski,et al.  Human Granulocytic Ehrlichiosis: A Case Series from a Medical Center in New York State , 1996, Annals of Internal Medicine.

[5]  F. Mazzella,et al.  A case of concurrent presentation of human ehrlichiosis and Lyme disease in Connecticut. , 1996, Connecticut medicine.

[6]  J. Dawson,et al.  Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Pollack,et al.  Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. , 1996, JAMA.

[8]  R. Nadelman,et al.  The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. , 1996, The American journal of medicine.

[9]  J. Dumler,et al.  Direct cultivation of the causative agent of human granulocytic ehrlichiosis. , 1996, The New England journal of medicine.

[10]  S. Telford,et al.  Ixodes dammini as a potential vector of human granulocytic ehrlichiosis. , 1995, The Journal of infectious diseases.

[11]  G. Wormser.  Duration of therapy for Lyme borreliosis. , 1995, The Journal of infectious diseases.

[12]  L. Magnarelli.  Current status of laboratory diagnosis for Lyme disease. , 1995, The American journal of medicine.

[13]  J. Bakken,et al.  Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging? , 1994, JAMA.

[14]  R. Dattwyler,et al.  Occurrence of Antibodies to Borrelia burgdorferi in Patients with Nonspirochetal Subacute Bacterial Endocarditis , 1993, Annals of Internal Medicine.

[15]  J. J. Schwartz,et al.  Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions , 1992, Journal of clinical microbiology.

[16]  M. Gerber,et al.  Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  M. Gerber,et al.  False positive serologic tests for Lyme disease after varicella infection. , 1991, The New England journal of medicine.

[18]  D. Persing.  Polymerase chain reaction: trenches to benches , 1991, Journal of clinical microbiology.

[19]  J. Anderson,et al.  Cross-reactivity of nonspecific treponemal antibody in serologic tests for Lyme disease , 1990, Journal of clinical microbiology.